Shvarts O - Search Results

1

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.

Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS. Lam JS, et al. Among authors: shvarts o. J Urol. 2005 Aug;174(2):466-72; discussion 472; quiz 801. doi: 10.1097/01.ju.0000165572.38887.da. J Urol. 2005. PMID: 16006866

2

Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.

Han KR, Pantuck AJ, Bui MH, Shvarts O, Freitas DG, Zisman A, Leibovich BC, Dorey FJ, Gitlitz BJ, Figlin RA, Belldegrun AS. Han KR, et al. Among authors: shvarts o. Urology. 2003 Feb;61(2):314-9. doi: 10.1016/s0090-4295(02)02163-5. Urology. 2003. PMID: 12597937

3

Kidney cancer management in 2004: an update for the practicing general urologist.

Lam JS, Shvarts O, Belldegrun AS. Lam JS, et al. Among authors: shvarts o. Curr Urol Rep. 2004 Feb;5(1):1-3. doi: 10.1007/s11934-004-0001-2. Curr Urol Rep. 2004. PMID: 14733829 Review. No abstract available.

4

Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience.

Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, Cindolo L, Han KR, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin DK, Figlin RA, Mulders PF, Belldegrun AS. Patard JJ, et al. Among authors: shvarts o. J Urol. 2004 Jun;171(6 Pt 1):2181-5, quiz 2435. doi: 10.1097/01.ju.0000124846.37299.5e. J Urol. 2004. PMID: 15126781

5

Changing concepts in the surgical management of renal cell carcinoma.

Lam JS, Shvarts O, Pantuck AJ. Lam JS, et al. Among authors: shvarts o. Eur Urol. 2004 Jun;45(6):692-705. doi: 10.1016/j.eururo.2004.02.002. Eur Urol. 2004. PMID: 15149740 Review.

6

Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans.

Shvarts O, Lam JS, Kim HL, Han KR, Figlin R, Belldegrun A. Shvarts O, et al. J Urol. 2004 Sep;172(3):867-70. doi: 10.1097/01.ju.0000135803.91207.b0. J Urol. 2004. PMID: 15310985

7

p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.

Shvarts O, Seligson D, Lam J, Shi T, Horvath S, Figlin R, Belldegrun A, Pantuck AJ. Shvarts O, et al. J Urol. 2005 Mar;173(3):725-8. doi: 10.1097/01.ju.0000152354.08057.2a. J Urol. 2005. PMID: 15711252

8

Staging of renal cell carcinoma: current concepts.

Shvarts O, Lam JS, Kim HL, Belldegrun AS. Shvarts O, et al. BJU Int. 2005 Mar;95 Suppl 2:8-13. doi: 10.1111/j.1464-410x.2005.05190.x. BJU Int. 2005. PMID: 15759349 Review. No abstract available.

9

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS. Lam JS, et al. Among authors: shvarts o. J Urol. 2005 Jun;173(6):1853-62. doi: 10.1097/01.ju.0000165693.68449.c3. J Urol. 2005. PMID: 15879764 Review.

10

Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.

Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS. Lam JS, et al. Among authors: shvarts o. Cancer. 2005 Jun 15;103(12):2517-25. doi: 10.1002/cncr.21127. Cancer. 2005. PMID: 15880379 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page